Enhanced angiogenesis with dl-3n-butylphthalide treatment after focal cerebral ischemia in RHRSP

Brain Research

Volumn 1289, Issue , 2009, Pages 69-78

  Liao, Song Jie ^a   Lin, Jian Wen ^a   Pei, Zhong ^a   Liu, Chun Ling ^b   Zeng, Jin Sheng ^a   Huang, Ru Xun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Cerebral infarction; dl 3n butylphthalide; HIF 1 ; Hypertension; VEGF

Indexed keywords

3 BUTYLPHTHALIDE; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BENZOFURANS; BRAIN ISCHEMIA; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HYPERTENSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 68649085975     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.018     Document Type: Article

References (29)

1. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., and Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22 (2002) 393-403
2. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., and Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107 (2006) 2705-2712
3. Chen J., Li Y., Zhang R., Katakowski M., Gautam S.C., Xu Y., Lu M., Zhang Z., and Chopp M. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res. 1005 (2004) 21-28
4. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
5. Freeman R.S., and Barone M.C. Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 85-92
6. Garcia J.H., Wagner S., Liu K.F., and Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26 (1995) 627-634 discussion 635
7. Guo H., Huang L., Cheng M., Jin X., Zhao Y., and Yi M. Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarction. Neurosci. Lett. 393 (2006) 56-59
8. Issa R., AlQteishat A., Mitsios N., Saka M., Krupinski J., Tarkowski E., Gaffney J., Slevin M., Kumar S., and Kumar P. Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8 (2005) 53-62
9. Jaquet K., Krause K., Tawakol-Khodai M., Geidel S., and Kuck K.H. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res. 64 (2002) 326-333
10. Kong X.B., Yang Z.K., Liang L.J., Huang J.F., and Lin H.L. Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication. World J. Gastroenterol. 6 (2000) 134-135
11. Li Y., Lu Z., Keogh C.L., Yu S.P., and Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood Flow Metab. 27 (2007) 1043-1054
12. Li Z.G., Wang J.F., Cheng J.D., Liu Y.W., Xing H.W., Wang Y., and Chen Y.C. Regularity of hypoxia inducible factor 1 alpha expression in acute myocardial ischaemia in rats. Chin. Med. J. (Engl.). 120 (2007) 162-165
13. Liu C.L., Liao S.J., Zeng J.S., Lin J.W., Li C.X., Xie L.C., Shi X.G., and Huang R.X. dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP. J. Neurol. Sci. 260 (2007) 106-113
14. Manoonkitiwongsa P.S., Schultz R.L., Whitter E.F., and Lyden P.D. Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains. Vascul. Pharmacol. 44 (2006) 316-325
15. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., and Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156 (2000) 965-976
16. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
17. Mu D., Jiang X., Sheldon R.A., Fox C.K., Hamrick S.E., Vexler Z.S., and Ferriero D.M. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol. Dis. 14 (2003) 524-534
18. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J. 13 (1999) 9-22
19. Oyamada N., Sone M., Miyashita K., Park K., Taura D., Inuzuka M., Sonoyama T., Tsujimoto H., Fukunaga Y., Tamura N., Itoh H., and Nakao K. The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia. Endocrinology 149 (2008) 3764-3777
20. Peng Y., Zeng X., Feng Y., and Wang X. Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats. J. Cardiovasc. Pharmacol. 43 (2004) 876-881
21. Pialoux V., Mounier R., Brown A.D., Steinback C.D., Rawling J.M., and Poulin M.J. Relationship between oxidative stress and HIF-1alpha mRNA during sustained hypoxia in humans. Free Radic. Biol. Med. 15 (2008) 321-326
22. Rothwell N.J., and Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18 (1995) 130-136
23. Speliotes E.K., Caday C.G., Do T., Weise J., Kowall N.W., and Finklestein S.P. Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res. Mol. Brain Res. 39 (1996) 31-42
24. Takata K., Yamauchi H., Tatsuno H., Hashimoto K., and Abo M. Is the ipsilateral cortex surrounding the lesion or the non-injured contralateral cortex important for motor recovery in rats with photochemically induced cortical lesions?. Eur. Neurol. 56 (2006) 106-112
25. Wang Y., Kilic E., Kilic U., Weber B., Bassetti C.L., Marti H.H., and Hermann D.M. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128 (2005) 52-63
26. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., and Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 17 (1985) 497-504
27. Xu H.L., and Feng Y.P. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol. Sin. 21 (2000) 433-438
28. Zeng J., Zhang Y., Mo J., Su Z., and Huang R. Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 29 (1998) 1708-1713 discussion 1713-4
29. Zhang Y., Wang L., Li J., and Wang X.L. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia. J. Pharmacol. Exp. Ther. 317 (2006) 973-979